Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Developmental Roadmap Toward Abdominal Adhesions Prevention Technologies.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2025
Same author

A Collaborative Data Sharing Platform to Accelerate Translation of Biomedical Innovations.

Bioengineering (Basel, Switzerland)·2025
Same author

Development of a High-throughput Morphological Assay for Evaluating Mesenchymal Stromal Cell-derived Extracellular Vesicle Modulation of Brain Pericyte Secretory Phenotype.

Stem cell reviews and reports·2025
Same author

Biomanufacturing in low Earth orbit: A paradigm shift.

Stem cell reports·2025
Same author

High throughput morphological screening identifies chemically defined media for mesenchymal stromal cells that enhances proliferation and supports maintenance of immunomodulatory function.

Stem cell research & therapy·2025
Same author

Microglia morphological response to mesenchymal stromal cell extracellular vesicles demonstrates EV therapeutic potential for modulating neuroinflammation.

Journal of biological engineering·2024

Related Experiment Video

Updated: Mar 23, 2026

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
08:01

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

10.9K

Identification of Predictive Gene Markers for Multipotent Stromal Cell Proliferation.

Ian H Bellayr1, Ross A Marklein2, Jessica L Lo Surdo2

  • 11 Division of Cellular and Gene Therapies, Tumor Vaccines and Biotechnology Branch, Center for Biologics and Evaluation Research , US Food and Drug Administration, Silver Spring, Maryland.

Stem Cells and Development
|April 3, 2016
PubMed
Summary

Researchers identified seven key gene markers to predict the proliferative quality of multipotent stromal cells (MSCs). This discovery aids in assessing cell therapy readiness without lengthy assays.

More Related Videos

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

784
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

7.0K

Related Experiment Videos

Last Updated: Mar 23, 2026

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
08:01

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

10.9K
Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

784
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

7.0K

Area of Science:

  • Stem Cell Biology
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Multipotent stromal cells (MSCs) possess differentiation and immunomodulatory potential crucial for regenerative therapies.
  • Cellular expansion is necessary for therapeutic MSC doses, but proliferation capacity declines with passaging.
  • Predicting MSC proliferative quality is essential for ensuring therapeutic efficacy.

Purpose of the Study:

  • To identify and validate gene markers that accurately predict the proliferative capacity of human bone marrow-derived MSCs.
  • To establish a reliable method for assessing MSC quality for cellular therapies.

Main Methods:

  • Microarray analysis of human bone marrow-derived MSCs correlated with proliferation assays.
  • Validation of candidate gene markers using reverse transcription quantitative polymerase chain reaction (RT-qPCR).
  • Assessment of MSC proliferative potential through confluency, EdU incorporation, and population doubling time.

Main Results:

  • Twenty-four genes significantly correlated with MSC proliferation across multiple passages.
  • Fifteen genes distinguished proliferative potential between passage 4 and passage 8 MSCs.
  • Seven specific genes (BIRC5, CCNA2, CDC20, CDK1, PBK, PLK1, SPC25) showed consistent correlation with MSC proliferation, independent of passage number.

Conclusions:

  • A panel of seven genes reliably predicts multipotent stromal cell proliferative quality.
  • This gene expression signature offers a potential in vitro assay to assess MSC readiness for cellular therapy.
  • The findings may streamline the quality control process for MSC-based regenerative medicine applications.